Detail akcie Genenta Sp ADS online

Business Summary: Genenta Science SpA is an Italy-based company engaged in clinical-stage biotechnology research. The Company focuses on the development of lentivirus-based gene and cell therapies in cancer. It uses gene-based cytokine delivery to activate the immune system within the tumor providing the anti-tumor response. The Company not only operates locally but also is present in global markets, including the United States.
Financial Summary: BRIEF: For the six months ended 30 June 2025, Genenta Science SPA (ADR) revenues was not reported. Net loss decreased 5% to EUR3.8M. Lower net loss reflects BIOLOGICAL PRODUCTS segment loss decrease of 25% to EUR3.4M. Basic Earnings per Share excluding Extraordinary Items increased from -EUR0.22 to -EUR0.20.